JSPRWJasper Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Jasper Therapeutics, Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JSPRWThis | $296144#7 | — | 0.2x#2 | — | — | 100.0%#3 | — | -0.0%#2 | — | — | -91.1%#3 | — |
| SABSW | $3M#2 | 0.1x#4 | 0.0x#1 | — | -100.0%#6 | 138.9%#1 | — | 6.2%#1 | — | — | — | — |
| CEROW | $3M#3 | — | — | — | — | — | — | — | — | — | 145.3%#1 | 4.9%#1 |
| CRIS | $2M#4 | 0.1x#3 | 0.5x#3 | 0.3x#3 | -13.4%#4 | 82.5%#4 | -60.5%#2 | -161.5%#3 | -87.3%#1 | — | — | — |
| SLXN | $2M#5 | 0.0x#2 | 42.9x#4 | — | — | 27.9%#7 | — | -27072.7%#4 | — | — | — | — |
| SCLXW | $1M#6 | — | — | 0.0x#1 | -46.5%#5 | -413.8%#8 | -1143.7%#3 | — | — | 4#1 | 107.0%#2 | — |
| ABPWW | $116152#8 | 0.0x#1 | — | 0.6x#4 | 50.0%#1 | 60.0%#5 | -4618.6%#4 | — | — | — | — | — |
| ABPO | — | — | — | — | 50.0%#1 | 60.0%#5 | -4618.6%#4 | — | — | — | — | — |
| ALVOW | $100M#1 | — | — | 0.2x#2 | 19.7%#3 | 112.0%#2 | 13.3%#1 | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice